COVID-19 has dramatically changed how we view care provision
Remote care has taken the main stage, yet many issues remain
COVID-19 has completely turned our daily lives upside down and shifted the entire focus of the care system to dealing with this major pandemic. However, regular care can't just stop, and many organizations are leaning far more heavily on remote care options than in the past. We hope these two research reports will help stakeholders better understand current offerings as well as considerations when planning implementations of these solutions. Be sure to contact us with any follow up questions or if you'd like to work more closely with Chilmark Research to think through your organization's needs and unique implementation requirements.
In addition to examining what traditional healthcare stakeholders must do to support telehealth beyond the hospital, this report considers the role of emerging stakeholders – a list that includes retail health, urgent care, employer-sponsored clinics, digital therapeutics solutions, and the “smart home” enabled by voice-activated virtual assistants. Together, these emerging stakeholders demonstrate how patients’ first point of interaction with healthcare services is quickly being disrupted by consumer-centric business models and technology solutions.
The report includes profiles of 12 vendors identified as representative market leaders due to factors such as brand awareness, market visibility, support for patient self-management, proven outcomes, ease of use, and product vision.
New methods of delivering technology-enabled primary care offer novel ways for patients to access care directly, for providers to gain greater visibility into the patient’s life and experience, and for both sides of the care loop to communicate. These technology solutions offer ways to not just improve care, but to support value-based payment models that will soon be the norm.
Each type of solution (Telehealth; Virtual & Remote Care Platforms; and AI-Enabled Assistants, Symptom Checkers and Chatbots) is evaluated based how it affects barriers to access, burden, and costs for both providers and patients. The report provides important information about use cases, subcategories of product offerings, reimbursement options, and other obstacles to adoption for each type of solution.